Gastrointestinal outcomes and confounders in cystic fibrosis

J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):273-85. doi: 10.1097/01.mpg.0000178439.64675.8d.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Child
  • Cystic Fibrosis / complications*
  • Cystic Fibrosis / mortality
  • Cystic Fibrosis / therapy*
  • Dietary Fats / metabolism
  • Disease Models, Animal
  • Exocrine Pancreatic Insufficiency / etiology*
  • Exocrine Pancreatic Insufficiency / mortality
  • Exocrine Pancreatic Insufficiency / therapy
  • Humans
  • Intestinal Absorption / drug effects
  • Mice
  • Pancreatic Elastase / therapeutic use*
  • Respiratory Tract Infections / etiology
  • Respiratory Tract Infections / mortality
  • Respiratory Tract Infections / therapy
  • Treatment Outcome

Substances

  • Dietary Fats
  • Pancreatic Elastase